Emerald Health Therapeutics Inc (EMH.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 19 | 11 | 13 | 12 | 11 |
| Accounts receivable | 8 | 9 | -17 | 26 | -17 |
| Accounts payable and accrued liabilities | -10 | N/A | N/A | N/A | 61 |
| Other Working Capital | 42 | 44 | -20 | -80 | 32 |
| Other Operating Activity | -528 | -487 | -610 | -615 | -651 |
| Operating Cash Flow | $-470 | $-423 | $-633 | $-658 | $-564 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -96 | -186 | -31 | -13 | -81 |
| Investing Cash Flow | $-96 | $-186 | $-31 | $-13 | $-81 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 501 | 619 | 333 | 2 | N/A |
| Other Financing Activity | -7 | 0 | 0 | 0 | -2 |
| Financing Cash Flow | $493 | $619 | $333 | $2 | $-2 |
| Beginning Cash Position | 82 | 72 | 402 | 1,071 | 1,719 |
| End Cash Position | 9 | 82 | 72 | 402 | 1,071 |
| Net Cash Flow | $-72 | $10 | $-331 | $-669 | $-647 |
| Free Cash Flow | |||||
| Operating Cash Flow | -470 | -423 | -633 | -658 | -564 |
| Capital Expenditure | -96 | -186 | -31 | -13 | -81 |
| Free Cash Flow | -566 | -609 | -664 | -671 | -645 |